Calcium phosphate crystal-associated proteins: α-2-HS-glycoprotein, prothrombin fragment 1 and osteopontin

International Journal of Urology

Volumn 8, Issue 8, 2001, Pages S58-S62

  Nishio, Shunji ^a   Hatanaka, Masayuki ^a   Takeda, Hajime ^a   Aoki, Katsunori ^b   Iseda, Tokuhiro ^c   Iwata, Hidenobu ^d   Yokoyama, Masayoshi ^e  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RESEARCH AND DEVELOPMENT   (Australia)

^d College of Chemistry and Molecular Engineering ^*  (China)

^e EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium phosphate crystals; Osteopontin; Prothrombin fragment 1; 2 HS glycoprotein

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; GLYCOPROTEIN; OSTEOPONTIN; PROTHROMBIN;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CRYSTALLIZATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN URINE LEVEL; SEX DIFFERENCE; STONE FORMATION; URINALYSIS;

ADULT; BLOOD PROTEINS; CALCIUM OXALATE; CRYSTALLIZATION; FEMALE; HUMANS; MALE; OSTEOPONTIN; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PROTEIN PRECURSORS; PROTHROMBIN; SIALOGLYCOPROTEINS; URINARY CALCULI;

EID: 0035569295     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2001.00336.x     Document Type: Article

References (24)

1. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted urine in vitro
2. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney
3. The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells
4. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects
5. Calcium oxalate crystallisation kinetics and the effects of calcium and γ-carboxyglutamic acid
6. Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine
7. The immunohistochemical distribution and quantification of crystal matrix protein
8. Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: Evidence of activation peptide of human prothrombin
9. Calcium oxalate crystal matrix extract: The most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro
10. Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin
11. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin
12. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi
13. Localization of Tamm-Horsfall protein and osteopontin in a rat nephrolithiasis model
14. Quantification of osteopontin in the urine of healthy and stone-forming men
15. Preparation and properties of the human plasma Ba-α2-glycoproteins
16. Origin of plasma α2-HS-glycoprotein and its accumulation in bone
17. Variations in the serum concentration and urine excretion of α2-HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta
18. Fetuin - An old friend revisited
19. The nucleotide and deduced amino acid structures of sheep and pig fetuin. Common structural features of the mammalian fetuin family
20. Generation of the combined prothrombin activation peptide (F1.2) during the clotting of blood and plasma
21. Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrix
22. Quantitation of prothrombin activation products in human urine
23. Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily
24. Osteopontin in urinary stone formation